From reading posts on another board, it raises some questions for the detractors. What is negative about Mullen and Chapman taking the lead in this company? Some real arguements please. 80% adverse events being claimed by detractors. I did not read this out of the Thyroid study. Please tell me how you come to that conclusion, when any mild events were alleviated by dosage adjustments. When thousands of people take AnataBloc, and don't report these adverse events, and report positive results for many conditions, are you going to keep exlpaining it away as a placebo effect? Or will you keep saying that paid pumpers are the only one's posting positive effects. From the looks of another board, somebody is desperate to keep STAR down. I have never seen such volume of posts and negative remarks as this for any stock that I have seen before. In conclusion, STAR is still speculative as a company, but no valid arguements against the science, and unsubstantiated attacks lead me to believe that this is still a worthwhile investment. Good health to all!!
